Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...

The latest trend in treating hair loss may sound familiar — essentially, it's a repurposed drug first popularized in the ...

Hims & Hers Health ( HIMS 3.08%) stock jumped 2.2% through 10:45 a.m. ET Monday after Morgan Stanley analyst Craig Hettenbach ...

"Hims," which advertises itself as an app for "hair loss, sexual health" and "Hers" which promotes "hair care, mental health." Morgan Stanley's research suggests the majority of downloads in ...

Can Hims Survive Without GLP-1s? Outside of weight loss, Hims’ core business is still strong. Sales of generic treatments for hair loss and erectile dysfunction jumped 43% in 2024, reaching $1.2 ...